Care for Patients with Type-2 Chronic Rhinosinusitis

Area of Science:

• Otolaryngology
• Immunology
• Epidemiology

Background:

• Growing interest in chronic rhinosinusitis (CRS) in medical literature over the past 20 years.
• Current epidemiological data on CRS prevalence is limited and based on heterogeneous populations and diagnostic methods.
• CRS presents with diverse clinical scenarios, significantly impacting quality of life and incurring substantial socioeconomic costs.

Purpose of the Study:

• To highlight the need for precise diagnostic and therapeutic strategies in chronic rhinosinusitis.
• To emphasize the importance of patient stratification through phenotypes and endotypes for tailored treatment.
• To advocate for a multidisciplinary approach in managing CRS, inspired by precision medicine models.

Main Methods:

• Review of recent research on chronic rhinosinusitis (CRS).
• Analysis of the challenges in current CRS prevalence studies.
• Exploration of precision medicine principles and multidisciplinary board models for application in CRS management.

Main Results:

• Chronic rhinosinusitis (CRS) is characterized by clinical heterogeneity and significant patient burden.
• Patient stratification into phenotypes and endotypes is essential for personalized treatment.
• A multidisciplinary approach, akin to oncological boards, is proposed for optimal CRS care.

Conclusions:

• Accurate prevalence data for chronic rhinosinusitis (CRS) is lacking.
• Tailored treatment requires understanding CRS phenotypes, endotypes, and comorbidities.
• Implementing precision medicine principles and multidisciplinary collaboration can enhance CRS patient outcomes and reduce societal costs.